India’s Sun Pharmaceutical Industries has agreed to acquire U.S.-listed Organon (NYSE: OGN) in an all‑cash transaction valuing the company at about $11.75–$11.8 billion, or $14 per share. The…
Veradermics hair loss trial update Veradermics’ (NYSE: MANE) lead candidate VDPHL01, an extended‑release oral minoxidil tablet, showed statistically significant hair growth versus placebo in men…
Organon ( $OGN) is ripping higher on renewed M&A chatter, after fresh reports that India’s Sun Pharmaceutical Industries is preparing an all‑cash takeover offer that could value the…
April 23, 2026
Gene Therapy Turns Hearing Back On: Regeneron Wins First‑in‑Class FDA Approval for OTOF‑Related Deafness
Regeneron Pharmaceuticals (NASDAQ: REGN ) has won FDA approval for DB‑OTO, a first-in-class gene therapy designed to treat a rare congenital hearing loss caused by…
April 22, 2026
AbbVie Bets Big on Durham: $1.4 Billion Campus to Power Its Next Generation of Medicines
AbbVie (NYSE: ABBV) is making a major long‑term bet on North Carolina, committing roughly 1.4 billion dollars to build a new manufacturing campus in Durham that…
April 21, 2026
BriaCell Highlights Potent Preclinical Anti‑Cancer Activity For Next‑Gen Bria‑OTS+ Platform
BriaCell Therapeutics (NASDAQ: BCTX) presented new preclinical data showing that its next‑generation Bria‑OTS+ off‑the‑shelf immunotherapy platform triggers strong, coordinated immune responses and robust tumor‑killing activity across…
Evommune (NYSE: EVMN) has built its pipeline around a single premise: that mast cell biology connects a range of chronic inflammatory conditions, from hives to…
April 16, 2026
Half of GLP-1 Patients Stop Taking Their Medication. Here Is What That Means for Lexaria.
GLP-1 drugs have become one of the biggest success stories in pharmaceuticals. In 2025, the top seven branded products generated more than $73 billion in…
April 14, 2026
Kailera Aims For Up To $533M+ Nasdaq IPO To Support China‑Derived Obesity Drug Pipeline
Kailera Therapeutics is marketing what could be one of the year’s largest biotech listings, targeting up to about $533 million in gross proceeds from a…
April 13, 2026
Allogene Stock Jumps As Off‑The‑Shelf CAR‑T Wipes Out Residual Lymphoma In Early Readout
Allogene Therapeutics (NASDAQ: ALLO) is up more than 50%, trading sharply higher after early data showed its off‑the‑shelf CAR‑T candidate cema‑cel eliminated lingering lymphoma cells far…
Shares of Sky Quarry Inc. (Nasdaq: SKYQ) are on the move, up 46% after a multi‑day surge that has taken the stock from roughly $2.50 at the…
Invivyd Inc. (NASDAQ: IVVD) jumped roughly 25% after investors digested fresh progress on its late‑stage COVID‑19 prevention program for monoclonal antibody VYD2311. The move comes as…